Pfizer Recalls More Than 100,000 Bottles of Effexor XR
Pfizer Inc. (NYSE:PFE) is recalling two lots of its antidepressant drug Effexor XR, as well as one lot of the generic version of the drug, after a pharmacist reported that one bottle of Pfizer’s...
View ArticleHere’s Why Pfizer’s Holding on to Its Celebrex Patent With Both Hands
Patent expirations continue to be a problem for the United States’ largest pharmaceutical manufacturers. Since Pfizer’s (NYSE:PFE) patent for its blockbuster cholesterol medicine Lipitor — which for...
View ArticleBristol-Myers and Pfizer Win Approval of New Indication for Eliquis
Bristol-Myers Squibb & Co. (NYSE:BMY) and Pfizer Inc. (NYSE:PFE) announced today that the FDA has approved an additional indication of Bristol’s anti-blood clot medicine, Eliquis. The drug is now...
View ArticleCould Pfizer Be Considering a Grab for AstraZeneca’s Cancer Pipeline?
Source: Thinkstock Reuters, Bloomberg, and Forbes report that Pfizer, Inc.(NYSE:PFE) – currently the world’s largest pharmaceutical company — has been contemplating a takeover of AstraZeneca, an...
View Article6 Drugs That Could Move the Pharma Market
Overview In the last few years, a number of promising drugs that treat serious conditions and diseases have come through drugmakers’ pipelines. Recent developments in oncology, for instance, mean that...
View ArticleIs Big Pharma Ready to Jump Into the Marijuana Market?
Source: Thinkstock The pharmaceutical market has become an ever-evolving industry that, at times, has a similar feeling to the wild west. As biotech companies grow and manufacturers continue to find...
View ArticleBritain Demands Stronger Commitments From Pfizer in AstraZeneca Deal
U.K. Prime Minister David Cameron has become more outspoken about the potential takeover of AstraZeneca Group Plc (NYSE:AZN), which is based in Slough, England, by American pharmaceutical giant Pfizer...
View ArticleMerger Frenzy: Pfizer Commits to Britain, Allergan Rejects Valeant
Source: Thinkstock In the latest news from the throes of pharma’s ongoing merger drama, Pfizer, Inc. (NYSE:PFE) has responded to earlier concerns raised by the British prime minister regarding the...
View ArticleNew Filings Reveal How Pfizer’s Executives Made Millions in February
Source: Thinkstock Even if Pfizer, Inc. (NYSE:PFE) doesn’t succeed in its bid for AstraZeneca Group Plc. (NYSE:AZN), it seems Pfizer’s executives will be doing just fine. The Guardian reported on...
View ArticlePfizer’s Fourth and ‘Final’ Offer for AstraZeneca Fails
Source: Thinkstock Ending weeks of speculation, AstraZeneca’s (NYSE:AZN) board has officially rejected American pharmaceutical giant, Pfizer Inc. (NYSE:PFE), and its final offer, according to a press...
View ArticlePfizer Wins Exclusivity on Lyrica Until 2018
Pfizer Inc. (NYSE:PFE) has won a court ruling that effectively blocks all generic competition of the company’s top-selling product, Lyrica, a pain medicine. Generic competitors won’t be allowed to...
View ArticlePfizer Recalls More Than 100,000 Bottles of Effexor XR
Pfizer Inc. (NYSE:PFE) is recalling two lots of its antidepressant drug Effexor XR, as well as one lot of the generic version of the drug, after a pharmacist reported that one bottle of Pfizer’s...
View ArticleBristol-Myers and Pfizer Win Approval of New Indication for Eliquis
Bristol-Myers Squibb & Co. (NYSE:BMY) and Pfizer Inc. (NYSE:PFE) announced today that the FDA has approved an additional indication of Bristol’s anti-blood clot medicine, Eliquis. The drug is now...
View ArticleCould Pfizer Be Considering a Grab for AstraZeneca’s Cancer Pipeline?
Source: Thinkstock Reuters, Bloomberg, and Forbes report that Pfizer, Inc.(NYSE:PFE) – currently the world’s largest pharmaceutical company — has been contemplating a takeover of AstraZeneca, an...
View Article6 Drugs That Could Move the Pharma Market
Overview In the last few years, a number of promising drugs that treat serious conditions and diseases have come through drugmakers’ pipelines. Recent developments in oncology, for instance, mean that...
View ArticleIs Big Pharma Ready to Jump Into the Marijuana Market?
Source: Thinkstock The pharmaceutical market has become an ever-evolving industry that, at times, has a similar feeling to the wild west. As biotech companies grow and manufacturers continue to find...
View ArticleBritain Demands Stronger Commitments From Pfizer in AstraZeneca Deal
U.K. Prime Minister David Cameron has become more outspoken about the potential takeover of AstraZeneca Group Plc (NYSE:AZN), which is based in Slough, England, by American pharmaceutical giant Pfizer...
View ArticleMerger Frenzy: Pfizer Commits to Britain, Allergan Rejects Valeant
Source: Thinkstock In the latest news from the throes of pharma’s ongoing merger drama, Pfizer, Inc. (NYSE:PFE) has responded to earlier concerns raised by the British prime minister regarding the...
View ArticleNew Filings Reveal How Pfizer’s Executives Made Millions in February
Source: Thinkstock Even if Pfizer, Inc. (NYSE:PFE) doesn’t succeed in its bid for AstraZeneca Group Plc. (NYSE:AZN), it seems Pfizer’s executives will be doing just fine. The Guardian reported on...
View ArticlePfizer’s Fourth and ‘Final’ Offer for AstraZeneca Fails
Source: Thinkstock Ending weeks of speculation, AstraZeneca’s (NYSE:AZN) board has officially rejected American pharmaceutical giant, Pfizer Inc. (NYSE:PFE), and its final offer, according to a press...
View Article
More Pages to Explore .....